Dr. Wyatt receives CCS Impact Grant for prostate cancer precision oncology

Date Posted: 
2020-06-24

Dr. Alex Wyatt has been award a Canadian Cancer Society Impact Grant for his project, "Practical genomic stratification to enable tailored treatment of DNA repair defective prostate cancer." This five-year project will screen blood samples from metastatic castration-resistant prostate cancer patients across Canada in order to identify the subset whose tumours are defective in specific classes of DNA damage repair. These patients will be selectively treated on the basis of their results, using chemotherapy or immunotherapy. By combining genomic screening expertise with a national clinical trial network, the goal is to improve Canadian patient access to emerging therapies and advance a precision-medicine approach to care.

Dr. Wyatt's grant and the eight other awarded projects are listed at the Canadian Cancer Society website.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

VPC Terry Fox team 2016

Terry Fox Run - September 20, 2020

The 40th annual Terry Fox Run takes place on Sunday September 20 across Canada, as a virtual event.  Please consider donating to or joining our TFRI-VPC team as we raise funds to enable The Terry Fox Foundation & The Terry Fox Research Institute to continue their support of innovative and progressive cancer research programs

Employment

Work at the Vancouver Prostate Centre

Thursday, September 24, 2020

Drs. Gleave, Lack and Wang awarded CIHR Project Grants

Tuesday, September 8, 2020

MSFHR 2020 Awardees: Drs. Hach, Gentile, Massah

Thursday, June 25, 2020

Drs. Cherkasov and Jean receive CIHR grant to find new antiviral drugs to treat COVID-19